| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 14657 | 2009 |
| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 2557 | 2017 |
| Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ... Ep Europace 17 (10), 1467-1507, 2015 | 1780 | 2015 |
| Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term … JW Eikelboom, L Wallentin, SJ Connolly, M Ezekowitz, JS Healey, ... Circulation 123 (21), 2363-2372, 2011 | 1557 | 2011 |
| Colchicine in patients with chronic coronary disease SM Nidorf, ATL Fiolet, A Mosterd, JW Eikelboom, A Schut, TSJ Opstal, ... New England journal of medicine 383 (19), 1838-1847, 2020 | 1525 | 2020 |
| European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation H Heidbuchel, P Verhamme, M Alings, M Antz, W Hacke, J Oldgren, ... Europace 15 (5), 625-651, 2013 | 1287 | 2013 |
| Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis … L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ... The Lancet 376 (9745), 975-983, 2010 | 1200 | 2010 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 983 | 2018 |
| Dronedarone in high-risk permanent atrial fibrillation SJ Connolly, AJ Camm, JL Halperin, C Joyner, M Alings, J Amerena, ... New England Journal of Medicine 365 (24), 2268-2276, 2011 | 831 | 2011 |
| “Brugada” syndrome: clinical data and suggested pathophysiological mechanism M Alings, A Wilde Circulation 99 (5), 666-673, 1999 | 673 | 1999 |
| EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary H Heidbuchel, P Verhamme, M Alings, M Antz, W Hacke, J Oldgren, ... European heart journal 34 (27), 2094-2106, 2013 | 576 | 2013 |
| Left atrial appendage occlusion during cardiac surgery to prevent stroke RP Whitlock, EP Belley-Cote, D Paparella, JS Healey, K Brady, M Sharma, ... New England Journal of Medicine 384 (22), 2081-2091, 2021 | 506 | 2021 |
| Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly, L Dyal, ... Gastroenterology 157 (3), 682-691. e2, 2019 | 468 | 2019 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 415 | 2018 |
| Subcutaneous or transvenous defibrillator therapy RE Knops, LRA Olde Nordkamp, PPHM Delnoy, LVA Boersma, J Kuschyk, ... New England Journal of Medicine 383 (6), 526-536, 2020 | 402 | 2020 |
| Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES T Vanassche, MN Lauw, JW Eikelboom, JS Healey, RG Hart, M Alings, ... European heart journal 36 (5), 281-288, 2015 | 397 | 2015 |
| Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial JD Easton, RD Lopes, MC Bahit, DM Wojdyla, CB Granger, L Wallentin, ... The Lancet Neurology 11 (6), 503-511, 2012 | 383 | 2012 |
| The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study SJ Connolly, L Wallentin, MD Ezekowitz, J Eikelboom, J Oldgren, ... Circulation 128 (3), 237-243, 2013 | 377 | 2013 |
| Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients LRC Dekker, CR Bezzina, JPS Henriques, MW Tanck, KT Koch, ... Circulation 114 (11), 1140-1145, 2006 | 337 | 2006 |
| Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial M Rienstra, AH Hobbelt, M Alings, JGP Tijssen, MD Smit, J Brügemann, ... European heart journal 39 (32), 2987-2996, 2018 | 325 | 2018 |